Nightingale Health Oyj engages in the development of health data platform for healthcare service providers. Its blood analysis technology utilizes nuclear magnetic resonance and proprietary software to provide health data that links a person's lifestyle to disease risk. The company was founded by Antti Juhana Kangas, Juha Pekka Pöysä, Satu Saksman, Pasi Soininen, Teemu Pentti Suna, and Peter Würtz in 2002 and is headquartered in Helsinki, Finland.